Article Details

FDA grants marketing approval for neuromodulation device to reduce fibromyalgia symptoms

Retrieved on: 2022-05-20 18:46:51

Tags for this article:

Click the tags to see associated articles and topics

FDA grants marketing approval for neuromodulation device to reduce fibromyalgia symptoms. View article details on hiswai:

Excerpt

The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up